NPTH — NeuPath Health Cashflow Statement
0.000.00%
Last trade - 00:00- CA$18.84m
- CA$27.48m
- CA$72.81m
- 55
- 94
- 86
- 93
Annual cashflow statement for NeuPath Health, fiscal year end - December 31st, CAD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -5.06 | -3.23 | -4.28 | -0.191 | -0.485 |
| Depreciation | |||||
| Deferred Taxes | |||||
| Non-Cash Items | 3.18 | 1.16 | 2.14 | 0.104 | 0.895 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -1.26 | 1.18 | 0.241 | 0.555 | -0.04 |
| Change in Accounts Receivable | |||||
| Change in Other Assets | |||||
| Change in Payable / Accrued Expenses | |||||
| Change in Taxes Payable | |||||
| Change in Other Liabilities | |||||
| Cash from Operating Activities | -0.646 | 1.92 | 0.738 | 3.03 | 2.61 |
| Capital Expenditures | -0.038 | -0.411 | -1.67 | -0.353 | -0.948 |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | 2.72 | -3.09 | 0 | 1.94 | -0.159 |
| Acquisition of Business | |||||
| Sale of Business | |||||
| Sale of Fixed Assets | |||||
| Change in Net Intangibles | |||||
| Cash from Investing Activities | 2.68 | -3.5 | -1.67 | 1.59 | -1.11 |
| Financing Cash Flow Items | — | — | — | — | 0.122 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 7.93 | -3.37 | -3.45 | -2.96 | -1.75 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 9.97 | -4.95 | -4.39 | 1.66 | -0.254 |